expresspharmaNovember 27, 2020
Tag: Narendra Modi , SII , Gennova , COVID-19 vaccine
Prime Minister Narendra Modi will visit the Pune-based Serum Institute of India on November 28, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said on Thursday.
The Central Drug Standard Control Organisation has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are the Serum Institute of India (SII) and the Gennova Biopharmaceuticals.
“We have received a confirmation about PM Modi’s visit to the Serum Institute of India on Saturday, but his minute-to -minute programme is yet to be received,” Saurabh Rao, Divisional Commissioner, Pune.
On Tuesday, Rao said there was a possibility of the PM’s visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.
Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals here on December 4.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: